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Unravelling Receptor and RGD 
Motif Dependence of Retargeted 
Adenoviral Vectors using Advanced 
tumor Model Systems
M. chernyavska1, M. Schmid2, p. c. freitag2, V. palacio-castañeda1, A. piruska3, 
W. t. S. Huck3, A. plückthun2 & W. p. R. Verdurmen1*
Recent advances in engineering adenoviruses are paving the way for new therapeutic gene delivery 
approaches in cancer. However, there is limited knowledge regarding the impact of adenoviral 
retargeting on transduction efficiency in more complex tumor architectures, and the role of the 
RGD loop at the penton base in retargeting is unclear. to address this gap, we used tumor models of 
increasing complexity to study the role of the receptor and the RGD motif. Employing tumor-fibroblast 
co-culture models, we demonstrate the importance of the RGD motif for efficient transduction in 
2D through the epithelial cell adhesion molecule (EpCAM), but not the epidermal growth factor 
receptor (EGFR). Via optical clearing of co-culture spheroids, we show that the RGD motif is required 
for transduction via both receptors in 3D tumor architectures. We subsequently employed a custom-
designed microfluidic model containing collagen-embedded tumor spheroids, mimicking the interplay 
between interstitial flow, extracellular matrix and adenoviral transduction. Image analysis of on-chip 
cleared spheroids indicated the importance of the RGD motif for on-chip adenoviral transduction. 
together, our results show the interrelationship between receptor characteristics, the RGD motif, the 
3D tumor architecture and retargeted adenoviral transduction efficiency. The findings are important for 
the rational design of next-generation therapeutic adenoviruses.
Currently, the field of gene therapy is witnessing a revival, with three new FDA approvals in 2017 and many novel 
approaches being pursued in preclinical research and clinical trials1. Adenoviral vectors have multiple advantages 
for gene therapy applications, such as high transduction efficiency in dividing and post-mitotic cells, extremely 
low risk of insertional mutagenesis and high payload capacity2. This is especially true for the so-called ‘gutless’ 
viruses which are free of viral genes. Human adenovirus serotype 5 (HAdV5) is the most studied adenovirus and 
has been extensively used as a vector for gene therapy2,3, but other serotypes are now being investigated as well.
HAdV5 infects cells in a two-step mechanism. The trimeric fiber knob, situated at the tip of the fibers located 
within the penton, interacts with the coxsackie-adenovirus receptor (CAR)4. Subsequently, an Arg-Gly-Asp 
(RGD) loop within the penton interacts with αV integrins of the target cell, required for efficient virus internali-
zation and endosomal escape5,6. Harnessing the benefits of HAdV5-based therapies requires overcoming several 
challenges: the virus must be targeted to the desired tissue, and it must be detargeted from its inherent liver tro-
pism and protected from the immune system2,7,8. If a gutless virus is to be used as a basis, an efficient production 
system must be developed9.
When describing efforts that have been made to overcome these challenges, it is useful to separate them 
into targeting, detargeting and overcoming the immune response. To alter targeting, the knob domain has been 
exchanged between serotypes10,11, but this cannot access completely new receptors. Peptides have been displayed 
on the knob12, but this can interfere with knob assembly and will not ablate binding to the original receptor. 
Using an anti-knob scFv fragment fused to epidermal growth factor (EGF)13, retargeting to the EGF receptor 
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(EGFR) was aimed for, but monovalent binding will be of limited affinity, and scFv fusions are notoriously 
aggregation-prone. In 2013, a flexible adapter system was developed based on the use of designed ankyrin repeat 
proteins (DARPins)14. Briefly, by trimerizing a knob-binding DARPin, and linking it by a flexible linker to a 
target-binding DARPin, a very general retargeting can be achieved, as the adapter binds very tightly, blocks bind-
ing of the knob to the original CAR, and high-affinity DARPins can be selected from very diverse libraries to 
bind to basically any target15. DARPins are small (~15 kDa) very robust proteins which fold well even as fusion 
proteins.
Recently, we reported in vivo experiments in which several approaches to target, to detarget and to avoid 
immune recognition were combined7. Targeting to different receptors was achieved by the adapter strategy14, liver 
tropism was reduced by introducing mutations in the hexon that eliminate factor X binding16, and by creating 
a high-affinity protein coat based on a trimerized scFv fragment binding to the hexon, the immune recognition 
was decreased in addition to a further decrease in liver tropism7. In the absence of the EGFR- or Her2-targeting 
adapter, it was observed that murine fibroblasts and fibrocytes were transduced when the virus was injected 
intratumorally.
While binding to integrins is not required for the cell association of the virion17, the RGD motif may contrib-
ute to fibroblast transduction by adenoviral vectors. Integrin expression is ubiquitous and particularly high on 
fibroblasts18. It is thus important to establish whether the association of the RGD motif with integrins is necessary 
for the infection process also when receptors other than CAR are being used for initial cell association. In this 
study, we therefore investigated the role of the RGD motif in transduction with adenoviral vectors retargeted to 
human EGFR and epithelial cell adhesion molecule (EpCAM), both on tumor cells and on fibroblasts, using the 
adapter strategy described above7,14. We utilized both 2D monolayer tumor-fibroblast co-cultures and 3D sphe-
roid co-culture models. The use of 3D models is particularly relevant in this context, as integrin expression levels, 
accessibility and downstream signaling activity can differ widely between conventional 2D and more complex 
3D systems that can contain extracellular matrix materials19–22. On the other hand, for mechanistic investigations 
regarding the role of the RGD motif, 3D model systems are much more tractable than in vivo models. We also 
employed a tumor-on-a-chip microfluidic device designed for capturing spheroids. Microfluidic devices can be 
employed to experimentally model tumor-specific features in a controlled manner, including the presence of 
multiple cell types, extracellular matrices (ECM), concentration gradients, fluid flow as well as the addition of 
therapeutic agents to the tumor23. Using co-culture models in combination with optical clearing of 3D tumor 
cell cultures, we demonstrate the receptor-dependent role of the RGD motif and its different role in 2D and 3D 
cultures.
Results
Luciferase assay: cell line screening and model selection. To select appropriate models for the inves-
tigation of the role of the RGD motif at the penton base in transduction with retargeted adenoviral vectors in 
3D static and microfluidic tumor models, we first screened individual cell lines by retargeting HAdV5 towards 
different tumor cell markers. These cell lines would then be used in co-culture models. We compared the CAR-
mediated transduction of naked virus (both as a WT with intact RGD and ΔRGD) to transduction with retar-
geted viruses by DARPin-based retargeting adapters14 to either Her2, EGFR, Her3 or EpCAM, again using WT 
and ΔRGD viruses.
For this purpose, we used a series of tumor cell lines that have been described in the literature to express one 
or several of these receptors (Supplementary Table S1), as well as two primary fibroblast cell lines: IMR-90 (lung) 
and C5120 (skin).
We aimed to identify two co-culture models for subsequent studies: one model where both fibroblasts and 
tumor cells would be transduced and a second model where preferentially tumor cells would be transduced. A 
model where both tumor cells and fibroblasts are transduced would allow us to investigate factors arising from 
either the 3D tumor context or the virus structure that are important for transduction of both cell types. In con-
trast, the second model could serve as a lead for generating next-generation adenoviral delivery systems with a 
further enhanced specificity regarding the transduction of tumor cells. Using luciferase-encoding virus, we meas-
ured luciferase activity 48 h after transduction of 2D monolayer cultures of a series of tumor cell lines.
In tumor cells, use of a DARPin adapter targeting to an overexpressed receptor led mostly to an increased 
transduction, compared to the non-binding DARPin E2_5 (Supplementary Fig. S1).
Interestingly, rather different consequences regarding the effect of the deletion of the RGD motif in the penton 
base were observed depending on which receptor was targeted. For CAR-mediated transduction (in the absence 
of any adapter), a pronounced decrease in transduction level by ΔRGD was observed only in C5120 cells, while 
virtually no decrease was observed in the remaining tested cell lines. If the virus is coated with an adapter that 
blocks all binding interactions via the knob protein and carries the non-targeting control E2_5 DARPin, strongly 
decreased transduction efficiency of ΔRGD viruses compared to the WT virus was observed for all cell lines 
except for SKOV-3 cells, where only a minor decrease in transduction efficiency was observed. Remarkably, 
in MCF-7 cells (Supplementary Fig. S1), the knob-blocked ΔRGD virus gave no detectable signal, using the 
highly sensitive luciferase assay, while transduction was detected for the knob-blocked WT virus and for the 
non-blocked ΔRGD virus. The transduction with the knob-blocked WT virus is in line with previous observa-
tions of essentially no CAR expression and an important role of αvβ5 integrins in AdV transduction of MCF-7 
cells24. The interaction partner on the virus that rescues transduction with non-blocked ΔRGD virus (which is 
expected to transduce only through CAR and not through αvβ5 integrins) remains undefined, but could be either 
residual CAR or yet another unidentified interaction partner of the knob.
When comparing transduction through the tumor marker-specific adapters, we observed that transduction 
through EpCAM was lower for the ΔRGD virus in all tumor cell lines as well as in both fibroblast cell lines 
(P < 0.0001 for the effect of the ΔRGD modification on EpCAM-retargeted virus across all tested cell lines, vs. 
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P = 0.0002 for the decreased activity of the ΔRGD modification on non-retargeted virus). For retargeting to the 
other receptors, no strong trends were observed. Of note, EGFR-mediated transduction was very high in A-431 
cells and in both fibroblast cell lines, and showed no decreased transduction efficiency for the ΔRGD viruses. 
This suggests that the high efficiency seen for EGFR-mediated adenoviral transduction is not dependent on the 
interaction of the RGD motif with integrins.
Based on these data, we decided to continue with two co-culture models: first, A-431 and C5120 cells, which 
can both be efficiently transduced with EGFR-retargeted HAdV5, where there is no apparent effect of the RGD 
motif; second, MCF-7 and C5120, where tumor cells are preferentially transduced and where the RGD motif 
contributes considerably to the transduction efficiency. We quantified receptor levels of EpCAM and EGFR on 
these cell lines, and could confirm that for EGFR, levels were very high on A-431 cells, moderate-to-low on C5120 
fibroblasts and low on MCF-7 cells (Supplementary Fig. S2). For EpCAM, levels were highest on MCF-7 cells, 
followed by A-431 cells; levels were very low on C5120.
Transduction efficiency of retargeted HAdV5 in co-cultures in 2D. We used wild-type and ΔRGD 
viruses encoding iRFP670 as a reporter in co-cultures of individually labelled cell types, in order to be able to 
identify the transduced cell type by means of flow cytometry and confocal microscopy. Employing monocultures 
as a reference, we wished to evaluate potential effects on transduction of mutual competition between the cell 
lines, for example for binding sites, due to the markedly higher receptor expression levels on tumor cells than on 
fibroblasts (Supplementary Fig. S2).
Corroborating findings from the luciferase assay, we observed in fibroblasts the highest transduction effi-
ciency with the EGFR-retargeted virus using flow cytometry (see Fig. 1a,b for WT, Supplementary Table S2 for 
ΔRGD), followed by transduction via retargeting to EpCAM and transduction with the virus only (presumably 
infecting via CAR). Surprisingly, a marginally higher transduction was observed for E2_5-blocked virus as com-
pared to virus only, which was evident for both the WT and ΔRGD virus. In contrast, the luciferase assay only 
showed an increase for the ΔRGD virus (Supplementary Fig. S1). A possible explanation for these findings is that 
the non-targeting control DARPin E2_5 non-specifically interacts with C5120 cells, leading to a relatively efficient 
transduction.
No statistically significant differences in trends were observed between fibroblast mono- and co-cultures, sug-
gesting there was no meaningful competition of the virus for receptors given the high levels of receptors present 
on the tumor cells. The results of the flow cytometry analysis were qualitatively supported by confocal microscopy 
images of the mono-culture and co-culture models transduced with EGFR- and EpCAM-retargeted adenovirus 
(Fig. 1c).
Similarly to the luciferase assay results, using flow cytometry we noted essentially no reduction for 
EGFR-mediated transduction efficiency with the ΔRGD mutant in comparison to the virus with the RGD motif 
in tumor cells from 2D fibroblast-tumor co-cultures (Fig. 2a,c). In contrast, a considerable decrease upon dele-
tion of the RGD motif was again observed for the EpCAM-retargeted transduction efficiency in MCF-7 cells 
(Fig. 2b,c).
Transduction efficiency of retargeted HAdV5 in co-cultures in 3D. Next, we investigated the viral 
transduction efficiency and specificity in 3D spheroid cultures grown in static conditions (in the absence of 
flow). Static spheroid co-cultures mimic non-vascularized tumor regions with little or no fluid flow present, thus 
making nutrient and therapeutic delivery dependent exclusively on diffusion25. The viral retargeting effect was 
also observed in 3D for WT viruses, although generally transduction efficiencies were far lower in 3D than in 
monolayer cultures (Fig. 2 shows results for tumor cells, Supplementary Table S3 for fibroblasts). In monolayer 
cultures, EGFR retargeting led to the highest mean HAdV5 transduction efficiency for A-431 cells, followed by 
fibroblasts. In 3D, however, the EGFR-retargeted transduction efficiency was greatly decreased for both A-431 
cells and fibroblasts, emphasizing the importance of 3D models as well as of geometric factors of access to the 
cells. In A-431 cells, transduction via CAR or EpCAM showed similar trends of more efficient transduction in 
monolayers (Fig. 2a,c). In 3D co-cultures with MCF-7 and C5120 cells, comparable trends were observed for the 
tumor markers (Fig. 2b,c, Supplementary Table S3), but CAR-mediated transduction was low in all conditions.
Significantly lower transduction efficiencies were also observed for ΔRGD viruses in 3D cultures compared 
to 2D cultures for all conditions, as quantified by flow cytometry (Fig. 2). In contrast to observations made in 2D 
cultures, however, transduction by ΔRGD viruses was generally lower in spheroids for retargeted, non-retargeted 
and blocked viruses, though different trends were observed for the different cell lines and targeted receptors 
(Fig. 2, Supplementary Table S3). In tumor cells, deletion of the RGD motif resulted in a mild reduction in trans-
duction efficiency with EpCAM-retargeted virus in A-431 cells and a moderate reduction in MCF-7 cells (Fig. 2). 
A less pronounced reduction was seen for the EGFR-retargeted virus, with the relative transduction efficiency 
being similar in both A-431 and MCF-7 cells.
Major reductions by the RGD motif deletion were, however, observed in fibroblast transductions 
(Supplementary Table S3). The transduction efficiency decreased greatly in co-cultures with A-431 cells with 
EGFR- and EpCAM-retargeted virus. In MCF-7 co-culture spheroids, the EpCAM-mediated transduction effi-
ciency of fibroblasts with ΔRGD virus was much lower as compared to the WT virus. Clearly, the reduction in the 
transduction efficiency of EpCAM-targeted ΔRGD viruses was more pronounced in 3D cultures as compared to 
2D cultures, suggesting independently contributing effects of both the type of receptor and the tumor architec-
ture. These findings underline the importance of 3D models for investigating transduction dependency in context 
with viral modifications.
Remarkably, in this 3D set-up, the transduction efficiency of targeting to the original receptor (i.e. CAR) 
resulted in comparable numbers of transduced tumor cells as with EGFR- and EpCAM-retargeted viruses. This 
contrasts to what was seen in 2D cultures, where CAR-mediated transduction was much less efficient.
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Visualization of transduction in optically cleared spheroid co-cultures. To observe the transduc-
tion of cells in their native architecture in co-culture 3D tumor spheroids, confocal imaging of spheroids was 
performed using a SeeDB-derived optical clearing protocol that is non-toxic and compatible with most fluores-
cent dyes, including fluorescent proteins26. In Fig. 3 and Supplementary Fig. S3, confocal microscopy of tumor 
cells and fibroblasts transduced with WT and ΔRGD HAdV5 is presented. In Supplementary Fig. S4, sequential 
Figure 1. Flow cytometry and confocal microscopy of HAdV5-transduced fibroblast mono- and co-cultures. 
(a) Overlay histogram plots of the normalized cell count of the iRFP670-encoding WT HAdV5-transduced 
fibroblasts are shown. HAdV5 was retargeted to EGFR and EpCAM with E01 and Ac2 DARPin adapters, 
respectively. HAdV5 only (i.e. CAR-directed) and HAdV5 complexed with the non-binding DARPin E2_5 
(i.e. knob-blocked) were used as controls. Representative plots are shown, n = 3. (b) Flow cytometry-based 
quantification of transduced fibroblasts in monoculture or in co-culture with tumor cells as in (a). A two-way 
ANOVA showed no significant effect of the culture condition (i.e. mono- vs. co-culture; P = 0.1926). Bars 
show relative transduction ± s.e.m., n = 3. (c) Confocal microscopy images of infection by EGFR-retargeted 
and EpCAM-retargeted HAdV5 are shown. C5120 fibroblasts were labelled with CellTrace Yellow (cyan), 
A-431 and MCF-7 cells were labelled with CFSE (green). iRFP670 was used for detection of virus-transduced 
cells. Representative images from two independent experiments with three images taken per condition per 
experiment are shown. The scale bars are 100 µm.
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Figure 2. Flow cytometry of transduced tumor cells from co-cultures with fibroblasts in monolayer and 
spheroids. Cells were transduced with WT HAdV5 and ΔRGD HAdV5. (a) Overlay histogram plots of the 
normalized cell count of iRFP670-encoding WT and ΔRGD HAdV5-transduced A-431 cells are shown. 
HAdV5 was retargeted to EGFR with the DARPin E01 adapter, and to EpCAM with the DARPin Ac2 adapter. 
HAdV5 only (i.e. CAR-directed) and HAdV5 complexed with the non-binding DARPin E2_5 adapter (i.e. 
knob-blocked) were used as controls. Representative plots are shown, n = 3. (b) Same as described in (a) 
for MCF-7 cells co-cultured with C5120 fibroblasts. (c) Flow cytometry-based quantification of tumor cells 
transduced with WT or ΔRGD viruses. Statistical analysis by two-way ANOVA showed transduction in 
3D cultures was significantly lower than transduction in 2D cultures for A-431 (WT: P = 0.0045; ΔRGD: 
P = 0.0008) and MCF-7 cells (WT: P = 0.014; ΔRGD: P = 0.0246). Bars show relative transduction ± s.e.m., 
n = 3. *indicates P < 0.05; ***indicates P < 0.001.
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Figure 3. Transduction of tumor spheroids with HAdV5 directed to EGFR or EpCAM. Confocal microscopy 
images of optically cleared A-431_C5120 (a) and MCF-7_C5120 (b) tumor spheroids (confocal slice from 
the centre) are shown, with the corresponding radial intensity profiles (c). C5120 fibroblasts were labelled 
with CellTrace Yellow (magenta), A-431 and MCF-7 cells were labelled with CFSE (green). iRFP670 was used 
for detection of the virus-transduced cells (red). EGFR retargeting was accomplished using the E01 adapter, 
EpCAM retargeting via the Ac2 adapter and the HAdV5 was blocked using the non-binding E2_5 adapter. 
Representative images are shown from two independent experiments, with three spheroids analysed per 
condition per experiment. The scale bars are 100 µm. (c) The fluorescence intensity of iRFP670 in the spheroids 
is represented via a radial intensity profile. The average fluorescence was plotted from the outer edge of the 
spheroid (0 μm) to the spheroid core. At least two spheroids measured per condition per experiment were 
analyzed. Two independent experiments were performed. EGFR, epidermal growth factor receptor. EpCAM, 
epithelial cell adhesion molecule.
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optical confocal slices of transduced co-culture tumor spheroids are shown that illustrate that fluorescence could 
be observed throughout the entire spheroid after the clearing protocol.
Generally, the confocal images corroborate the findings from flow cytometry (Figs.  2, 3ab). Interestingly, 
tumor cells and fibroblasts cluster together, rather than forming a homogenous distribution in the spheroids. 
The clusters of fibroblasts were localized more towards the centre of the spheroids in both A-431_C5120 and 
MCF-7_C5120 co-culture models, similar to what has been observed before in other spheroid co-cultures27–29. 
The localization of fibroblasts preferentially in the centre may have contributed to the very low transduction levels 
of fibroblasts that were observed in the flow cytometry analyses of co-culture tumor spheroids (Supplementary 
Table S3).
Unsurprisingly, the images indicate that the transduction of tumor spheroids is predominantly at the rim, 
although transduction of more centrally localized cells was observed as well, as can be seen from a quantitative 
analysis of rim-to-core fluorescence intensities (Fig. 3c) as well as Z-stacks of confocal images of the different 
conditions (Supplementary Fig. S4). In A-431_C5120 spheroids, we observed a gradual decrease of intensity 
towards the core. Similar observations were made for transduction with ΔRGD viruses (Supplementary Fig. S3). 
In MCF-7_C5120 spheroids, a comparable trend was observed, though a second peak for the knob-blocked viral 
transduction signal was seen more centrally, which is mainly due to transduction of the fibroblasts located in 
the core of the spheroid (Supplementary Fig. S5). This indicates the ability of the viral particles to diffuse to the 
spheroid core in the absence of a binding site barrier caused by a high density of receptors on the cells in the outer 
rim of the spheroid.
Confocal microscopy images of the monolayer co-cultures and spheroid co-cultures provide further insights 
regarding the differences arising from deleting the RGD motif (Supplementary Fig. S3). In 2D co-cultures, 
decreases in transduction efficiency for ΔRGD compared to WT were seen for EpCAM-targeted viruses in 
MCF-7_C5120 co-cultures. Contrasting this, in 3D co-cultures, decreases for both EpCAM- and EGFR-targeted 
ΔRGD variants were observed, though decreases were still much more pronounced for EpCAM-directed trans-
duction in MCF-7_C5120, compared to EGFR-directed transduction in A431_C5120 (Supplementary Fig. S3).
Effect of flow and extracellular matrix on viral transduction in tumor-on-a-chip. Subsequently, 
we investigated transduction with viral vectors in a microfluidic tumor-on-a-chip model. In contrast to the 
non-vascularized tumor model described above (tumor spheroids), the tumor-on-a-chip system was developed 
to model a perfused tumor. Small cross-channel connections in our design allow basic resemblance to a leaky 
vasculature in a model where the hydrostatic pressure can be controlled (Fig. 4a). We designed the device to 
capture spheroids on-chip in a collagen matrix, with separate channels for an inlet (i.e. capillary-mimicking) and 
outlet (i.e. lymph-mimicking) flow to mimic blood supply and lymph drainage. Devices were loaded with a sus-
pension of spheroids in collagen, and spheroids were captured by the corresponding elements in the main device 
compartment (Fig. 4b). A separate microfluidic device with tunable resistance was used to induce and adjust the 
interstitial flow through the tumor compartment (Supplementary Fig. S6).
To evaluate the trafficking of viral particles through the collagen matrix, we perfused EGFR-retargeted, Alexa 
Fluor 488-labelled viral particles through the chip containing collagen with A-431_C5120 spheroids (Fig. 4c). 
Using confocal image analysis, we quantified the intensity profile in multiple regions of interest (ROI) of the 
tumor compartment to analyse the viral particle distribution in the microfluidic device and its enrichment 
around spheroids (Supplementary Fig. S7). We observed a strong accumulation of the viral particles at the entry 
site into the collagen matrix, which could be explained by the formation of a ‘filter cake’, where a high concentra-
tion of viral particles at the collagen interface limits particle infiltration into the collagen. Beyond this initial layer, 
viral particles were distributed relatively evenly throughout the collagen, with a clear enrichment at the border of 
the spheroids (Fig. 4c, Supplementary Fig. S7), likely due to the interaction of the EGFR-targeting DARPin E01 
adapter with EGFR expressed on cells in the spheroid.
Finally, we compared the viral retargeting to EGFR on-chip in an A-431_C5120 co-culture model of HAdV5 
with and without the RGD motif (Fig. 4d,e). Following a 48-h perfusion, spheroids spread through the com-
partment and transduction was observed throughout the compartment, even though it was absent in the 
remaining core regions of the tumor spheroids, similar to what was seen under static conditions (Fig. 4e). A 
high-magnification image of the transduction with the WT and ΔRGD EGFR-retargeted virus on-chip shows 
limited transduction in spheroid cores (Supplementary Fig. S8). In contrast to the fibroblast localization 
in the tumor spheroids in the absence of flow, after 48 h in the microfluidic chip in the presence of flow, the 
collagen-embedded spheroids were significantly spread out and there was no evident enrichment of fibroblast 
in the remaining centre. We observed a non-significant trend towards lower efficiency of transduction with 
the ΔRGD virus than with the virus with the WT RGD, which is in line with the small differences that were 
observed when comparing WT versus ΔRGD viruses in static spheroids with EGFR-retargeted viruses (Fig. 4d, 
cf. Fig. 2). The method to quantify transduction on-chip on the basis of confocal images was validated through 
analysing results of an identical experiment by both microscopy and flow cytometry, yielding comparable results 
(Supplementary Fig. S9).
Discussion
At present there is still an insufficient understanding of the principles that underlie the transduction of adeno-
viruses retargeted to novel receptors, and how complex (tumor) architectures are involved. Furthermore, it is 
unclear what the interacting partners are for adenoviral transduction in the absence of any cognate receptor. In 
this study, using 2D and several 3D tumor models, we focused on the role of the integrin-binding RGD motif. 
Specifically, we investigated the role of the RGD motif in transduction when receptors other than CAR are being 
used for cell association, or when no receptor is targeted (and CAR targeting is blocked), in various types of 
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Figure 4. A tumor-on-a-chip device designed for capturing tumor spheroids and investigating viral 
transduction on-chip. (a) Schematic 3D representation of the tumor-on-a-chip device. The main tumor 
compartment with spheroid-capturing posts is indicated in grey, with capillary and lymph-mimicking 
channels in red and green, respectively. The outlet of the capillary-mimicking channel is connected to a tunable 
resistance chip (See Supplementary Fig. S6). Not drawn to scale. Supplementary Fig. S6 provides a drawing 
to scale. (b) Reconstructed image of the tumor compartment of the tumor-on-a-chip device freshly loaded 
with co-culture spheroids. The scale bar is 300 µm. (c) On-chip visualization of the trafficking of the retargeted 
adenovirus. Confocal microscopy images of tumor spheroids embedded in collagen on-chip perfused with 
Alexa Fluor 488-labelled, EGFR-retargeted adenovirus are shown. Tumor cells were stained with CellTrace 
Far Red. The green ridge indicates the interface between medium and the collagen gel where viral particles 
accumulate. Insets indicate viral particles enriched on the outer rim of the spheroids. The scale bar is 300 µm. 
High-resolution images of the viral particle enrichment at the spheroid rim are provided in Supplementary 
Fig. S7. (d) Quantification of the cellular transduction on-chip. The fraction of the virus-transduced A-431 and 
C5120 cells was determined via image analysis using Fiji software and plotted. Error bars reflect the s.e.m, n = 3. 
(e) On-chip transduction of tumor spheroids with EGFR-retargeted HAdV5 with or without the RGD motif. 
Confocal microscopy images of on-chip optically cleared tumor spheroids transduced with EGFR-retargeted 
HAdV5 (with and without RGD) and non-transduced controls are shown. C5120 fibroblasts were labelled with 
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fibroblast-tumor cell co-cultures. We demonstrate that removing the RGD motif in the capsid of retargeted ade-
noviral vectors has different consequences depending on which receptor is targeted. We also show that WT and 
ΔRGD viruses behave differently in 3D and 2D cultures, with ΔRGD viruses consistently showing a lower rela-
tive transduction in 3D when compared to WT viruses. In 2D cultures, this was receptor- and cell-line dependent.
We selected two tumor co-culture cell models, using EGFR and EpCAM as targetable receptors on tumors. 
EpCAM is abundantly expressed in primary tumors and metastases of most epithelial malignancies, but also in 
normal epithelia, albeit at lower levels and mainly in a basolateral location with sequestration in intercellular 
boundaries, where it is less accessible30. EGFR is overexpressed on many tumors, but at lower levels also on nor-
mal tissues and fibroblasts31,32. The tumor cell models we chose have been reported to be either low (MCF-7)24 or 
low to moderate (A-431)33 with respect to the natural receptor CAR, and exhibit therefore relatively low infection 
efficiency by WT HAdV5.
In monolayers, EGFR-directed adenoviral transduction was independent of the RGD motif (Fig. 2, 
Supplementary Figs. S1 and S3). This observation regarding EGFR in monolayer cultures is in line with a previous 
observation using adenoviruses retargeted to EGFR using a fusion protein containing epidermal growth factor, 
where the authors showed that a GRGDSP peptide could block transduction with WT adenoviruses, but not of 
EGFR-retargeted adenoviruses13. In contrast to the EGFR finding, for EpCAM retargeting a dependency on the 
RGD motif was observed in 2D tumor cell models (Fig. 2, Supplementary Figs. S1 and S3).
For transduction with WT adenoviruses via CAR, it is well known that the penton base and fiber play central 
roles in the initial uncoating and disassembly of adenoviruses. A drifting motion of CAR bound to the fiber in 
combination with binding of the penton base to immobile integrins via the RGD motif is believed to facilitate 
the extraction of the fiber from the viral capsid, thereby exposing the endosomolytic protein pVI6, which induces 
positive membrane curvature leading to endosomal escape34.
Shayakhmetov et al. investigated the effect of deletion of the RGD motif on the adenoviral transduction of 
HAdV5, which uses CAR as a primary attachment receptor, and HAdV35, which uses CD46 as a primary attach-
ment receptor35. They observed that regardless of the primary attachment receptor, the RGD deletion did not 
influence virus attachment, though significantly reduced viral internalization rate35, which would be in agreement 
with the model described above. Previous investigations of the mechanism of adenovirus infection have thus 
focused mainly on initial binding of adenoviruses to natural receptors, i.e. CAR and CD46, each of which can 
be exploited by a different subset of adenoviruses serotypes35,36. Here we mediated entry via receptors of rather 
different types, EpCAM and EGFR, whose behaviour with respect to internalization differs significantly. Whereas 
the internalization rate of EGFR is particularly high (0.08 min−1)37, the reported internalized fraction of 18.7% 
after 90 min for EpCAM appears to reflect a much slower internalization rate38.
Entry via EpCAM appears to require a similar mechanism as entry via CAR, suggesting a required confor-
mational change of the penton base to expose the protein VI for viral internalization and endosomal escape and 
participation of the RGD motif and integrins. In contrast, in case of the EGFR-mediated transduction, association 
of the knob-adapter complex with EGFR could already be sufficient to induce receptor internalization and pVI 
exposure with concomitant endosomal escape, thus not requiring the RGD motif. Whether this process induces 
a similar change in the penton base or whether subsequent endosomal escape employs different mechanisms will 
have to be the subject of future studies.
In 3D spheroids, a lower efficacy of ΔRGD viruses compared to WT viruses was not only seen for EpCAM 
retargeting, but also for EGFR retargeting. As mentioned above, for EGFR, this was not the case in 2D. Especially 
for fibroblasts, relative transduction via all receptors was greatly reduced for ΔRGD viruses compared to WT 
viruses (Supplementary Table S3). Since fibroblasts reside mostly in the core in 3D spheroid cultures, the most 
likely explanation is that the ΔRGD viruses have a reduced ability to access the receptors in the first place. Since 
fibroblasts express lower amounts of all the receptors under study than the tumor cells, the uptake by fibroblasts 
would be expected less efficient, and in the context of a smaller number of virions arriving there, a participation 
of integrins is conceivable.
Alternatively, it cannot be excluded that RGD-containing viruses interact with a different subset of integrins 
in 2D versus 3D, possibly leading to a relatively higher transduction efficiency in 3D for WT viruses compared to 
ΔRGD viruses. A mildly lower efficiency of the EGFR-retargeted ΔRGD virus compared to the EGFR-retargeted 
WT virus was also observed in the microfluidic tumor model (Fig. 4d).
We chose to focus on 3D systems for investigating the effect of removing the RGD motif because of known 
differences in the subset of integrins that are expressed in 2D and 3D culture systems as well as their functional 
differences. Integrins are obligate dimers consisting of an α and a β subunit that connect the extracellular matrix 
to the intracellular cytoskeleton. All five αV integrins, two β1 integrins (α5, α8) and αIIbβ3 recognize ligands con-
taining an RGD motif, which are present on a large variety of integrin ligands39. In 2D cell cultures on plastic 
substrates, cells massively upregulate the levels of β1 and several α integrin subunits in an attempt to establish 
sufficient cell-matrix interactions to maintain survival22. In 3D, but not in 2D, a transdominant inhibition of 
αvβ3 by a5β1 is caused by the high levels of integrin binding to fibronectin in a fibrillar matrix19. Hence, binding 
to fibronectin (which contains an RGD motif) depends on different integrins in 2D (αvβ3 and a5β1) versus 3D 
(α5β1 only). The different integrin signature is associated with enhanced biological activities of integrin-ligand 
interactions in 3D40. For example, in 2D there is lack of the ability of integrins to bidirectionally cross-modulate 
CellTrace Yellow (magenta), A-431 cells were labelled with CFSE (green). iRFP670 (red) was used for detection 
of the virus-transduced cells. Representative images from three independent experiments are shown. The scale 
bars are 200 µm.
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between β1 integrins and EGFR signaling via the mitogen-activated protein kinase pathway, as observed in a 3D 
basement membrane assay20.
Moreover, CAR expression in 3D is dependent on normal tissue physiology. A cancerous microenvironment 
has been shown to disrupt physiological interactions with the extracellular environment, leading to an altered 
subcellular distribution and higher overall CAR levels, increasing the susceptibility towards adenoviral infec-
tion41. For EpCAM, though tumor cells express EpCAM more homogenously and more accessibly as compared to 
normal epithelia30, tumor growth in 3D is associated with reduced EpCAM levels, which was hypothesized to be 
related to an epithelial-mesenchymal transition (EMT)42. Similarly, a consistently decreased EGFR expression was 
seen across a range of tumor cell lines when grown in 3D versus 2D43. Thus, the distinct receptor expression pro-
files in 2D versus 3D as well as the functional consequences thereof underscore the need to investigate potential 
effects of removing the RGD motif in adenoviral vectors in 3D cell culture systems, illustrated by the differential 
uptake patterns of EGFR-retargeted ΔRGD viruses versus WT viruses in 2D and 3D systems.
Furthermore, accessibility of target cells is an important aspect that is fundamentally different in 2D, where 
there is no barrier, compared to 3D, where the matrix and cells represent a physical barrier25,44 and the presence 
of a high density of ligands may represent an additional binding-site barrier (BSB)45. The BSB occurs when tight 
interactions between targeted viral particles and cells (e.g. via avidity effects) prevent deeper penetration of par-
ticles. Given the importance of interstitial flow and extracellular matrix in (viral) particle transport46, we addi-
tionally developed a microfluidic spheroid-capturing tumor-on-a-chip model that incorporates these elements, 
as these are absent in the 3D static spheroid cultures.
Analogous microfluidic systems have been developed for the study of drug delivery in 3D tumor cultures, 
mostly for the evaluation of nanoparticle transport in tumor cultures47–49, but without the presence of fibroblasts. 
We decided to incorporate fibroblasts not only to investigate cell-type specificity, but also to better mimic the 
physiological cancer environment. Notably, fibroblasts are present in most tumors and have significant effects on 
the development and properties of in vivo tumor spheroids, including the matrix composition and its stiffness 
and are known to participate in increasing intratumoral interstitial fluid pressure levels, thereby hampering drug 
delivery50.
conclusions
This study presents novel insights into the interplay between the transduction by retargeted adenoviruses and the 
targeted receptor. We demonstrate a receptor-dependent role of the RGD motif at the penton base of adenoviruses 
and show a lower infectivity of ΔRGD viruses, compared to similar WT adenoviruses, for all receptor-targeted 
adenoviruses in 3D tumor spheroids. We could show that the decision if ΔRGD adenoviruses are to be preferred 
for adenoviral vectors for therapeutic applications will ultimately depend on the target receptor, the need for high 
efficiency versus specificity, as well as the tolerance towards off-target effects. Importantly, the presented insights, 
generated through combining results from 2D cell culture systems with those from advanced 3D culture systems, 
will facilitate the rational engineering of novel adenoviral vectors towards specific applications.
Materials and Methods
Microfluidic device manufacturing and tumor-on-a-chip culture. Masters of the microfluidic devices 
were prepared by spin-coating SU8 photoresist (micro resist technology GmbH, Berlin, Germany) on 2-inch sili-
con wafers (Silicon materials, Pittsburgh, USA). Subsequent processing was done according to the manufacturer's 
standard protocols51. A master for spheroid loading was created in two steps: (1) 20-μm thick film (SU8 2025) was 
spun, processed and exposed to create cross channels (see the inset of Supplementary Fig. S6); (2) on the top of 
the undeveloped film another 180-μm thick film (SU8 2100) was spun, processed and exposed; during the second 
exposure the wafer was aligned to connect the capture chamber and side channels via the cross channels. Finally, 
the whole construct was developed. A master for the resistance chip was created by processing a single 100-μm 
thick film (SU8 2100). Schematics of the designs drawn to scale are presented in Supplementary Fig. S6. Devices 
were subsequently made by soft lithography using polydimethylsiloxane (PDMS; Sylgard-184 silicon elastomer 
kit, Dow Corning). After curing, PDMS pieces were removed from the master and the inlet and outlet holes were 
made with a biopsy punch (1.5 mm, Kai Industries). The PDMS pieces were bonded onto a cover glass no. 1.5 
by oxygen plasma treatment (Femto plasma system, Diener Electronic). Prior to spheroid loading, the tumor 
compartment of the microfluidic device was coated with a freshly prepared polydopamine solution (2 mg/ml 
dopamine hydrochloride (Sigma-Aldrich) in 10 mM Tris-HCl, pH 8.5) for 1 h at room temperature. Spheroids 
were loaded in a 4 mg/ml collagen solution (Rat tail collagen type I, Corning), prepared via the manufacturer's 
protocol, using a syringe pump (Harvard apparatus PHD Ultra). Following gelation of the collagen in the tumor 
compartment for 30 min at room temperature, the device was connected to the syringe with perfusion medium 
at the inlet of the capillary channel, and to the resistance chip with a tunable resistance (Supplementary Fig. S6) 
at the outlet of the capillary channel. A representative image of the loaded chip was taken with a ZOE Fluorescent 
Cell Imager (Bio-Rad). The device was perfused in a 37 ° C incubator for 48 h at a flow rate of 200 μl/h unless 
indicated otherwise. After the perfusion, the collagen-embedded spheroid culture was washed with PBS, fixed 
in 4% paraformaldehyde (PFA) in PBS for 30 min and optically cleared using a modified SeeDB protocol26, all at 
room temperature. The SeeDB solution is a refractive-index matching solution and mainly a saturated solution 
of fructose (80.2% wt/wt) in water with 0.5% α-thioglycerol to prevent the Maillard reaction. For on-chip optical 
clearing, the tumor compartment was perfused with 29% (w/v) D-(−)-fructose (Sigma-Aldrich) with 0.5% (v/v) 
α-thioglycerol for 2 h, then with 57.5% D-(−)-fructose/0.5% α-thioglycerol for 5 h, followed by perfusion with 
115% D-(−)-fructose/0.5% α-thioglycerol overnight. Perfusion was performed at a flow rate of 400 μl/h. The 
optically cleared collagen-embedded spheroids were analysed by confocal microscopy.
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transduction with adenoviral vectors. The DARPin-SHP adapters were expressed as described previ-
ously7. Adapters contained an N-terminal His10-Tag, which was cleaved off by 3 C protease and removed during 
the purification and was not present in the experiments. Replication-deficient human adenoviruses of serotype 
5 (HAdV5) encoding either firefly luciferase or iRFP670 under a CMV promoter were utilized. Both viruses had 
either a wild-type capsid (WT) with the RGD motif present at the penton base, or a capsid without the RGD motif 
(ΔRGD). The HAdV5 constructs are derived from the Agilent AdEasy system, and produced and purified as 
described previously7. Labelling of the WT adenovirus with Alexa488 N-hydroxysuccinimide for viral trafficking 
experiments was performed as described before7. Retargeted viral particles were formed by incubating viruses 
with a calculated 2:1 excess of bispecific DARPin-SHP trimeric adapters (containing the receptor specificity indi-
cated) over adenovirus fiber knobs in HEPES-buffered saline (HBS, 150 mM NaCl, 20 mM HEPES, pH 8.0) for 
2 h at room temperature, followed by a 10 min incubation with a 100-fold excess of knob-blocking DARPin 1D3_
SHP trimers (not containing any receptor-retargeting DARPin)14 (Supplementary Fig. S10), to block any residual 
free knob which could mediate CAR-based transduction. The retargeted virus was added to cell culture medium 
to a final concentration of 1,000 viral particles/cell; for viral particle trafficking experiments, the viral particle con-
centration was 1.0 × 109 viral particles/ml. For transduction of spheroids, the viral particle-containing medium 
was added in hanging drops. For on-chip transduction, the viral particle-containing medium was perfused with 
a syringe pump at 1.0 × 108 viral particles/ml.
Cell culture (monolayer, 3D spheroid), luciferase assay, confocal microscopy, flow cytometry 
and statistical analyses. For details on the abovementioned procedures, please see the Supplementary 
Methods section.
List of Abbreviations. CAR, coxsackievirus and adenovirus receptor; CFSE, carboxyfluorescein succinim-
idyl ester; DARPin, designed ankyrin repeat protein; ECM, extracellular matrix; EGFR, epidermal growth factor 
receptor; EpCAM, epithelial cell adhesion molecule; HAdV5, human adenovirus serotype 5; HER2, human epi-
dermal growth factor receptor 2; HER3, human epidermal growth factor receptor 3; PDMS, polydimethylsiloxane.
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All data generated during and/or analysed during the current study are available from the corresponding author 
on reasonable request.
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